Joanne Lysaght

4.5k citations

95 papers · 3.3k indexed · h-index 30

Oncology top 2%
- Cancer Immunotherapy and Biomarkers 32
Immunology top 5%
- Immune Cell Function and Interaction 24
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 11
Cancer Research top 5%
- Cancer, Lipids, and Metabolism 9
Physiology top 5%
Surgery top 5%
- Esophageal Cancer Research and Treatment 29
Epidemiology
- Adipokines, Inflammation, and Metabolic Diseases 10
Pulmonary and Respiratory Medicine
- Gastric Cancer Management and Outcomes 9

Co-authors: John V. Reynolds Claire L. Donohoe Graham P. Pidgeon Suzanne L. Doyle Melissa J. Conroy Stephen Todryk Kingston H. G. Mills Andrew Jarnicki
Cited by: Oncology Immunology Cancer Research
Journals: Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)The Journal of Immunology (2 papers)
Partner nations: Ireland Canada United Kingdom

In The Last Decade

Joanne Lysaght

94 papers receiving 3.3k citations

Peers

Countries citing papers authored by Joanne Lysaght

Since Specialization

Citations

This map shows the geographic impact of Joanne Lysaght's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Lysaght with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Lysaght more than expected).

Fields of papers citing papers by Joanne Lysaght

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Lysaght. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Lysaght. The network helps show where Joanne Lysaght may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joanne Lysaght, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joanne Lysaght Line = papers co-authored together Joanne Lysaght links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma Biomedicines ·Maria Davern,Cillian O’ Donovan,Noel E. Donlon,Eimear Mylod,Caoimhe Gaughan,Anshul Bhardwaj,Andrew D. Sheppard,Dara Bracken‐Clarke,Christine Butler,Narayanasamy Ravi,Claire L. Donohoe,John V. Reynolds,Joanne Lysaght,Melissa J. Conroy	2024	2
2	The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy Cancer Letters ·Brendan Moran,Maria Davern,John V. Reynolds,Noel E. Donlon,Joanne Lysaght	2023	40
3	PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours Translational Oncology ·Maria Davern,Marie-Claire Fitzgerald,Croí E. Buckley,Aisling B. Heeran,Noel E. Donlon,Jason McGrath,Fiona O’ Connell,Malvika R. Deshpande,Conall Hayes,Jamie Macdonald,Andrew D. Sheppard,John V. Reynolds,Stephen G. Maher,Niamh Lynam‐Lennon,Brona M. Murphy,Joanne Lysaght	2022	6
4	Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy Journal of Cancer Research and Clinical Oncology ·Maria Davern,Noel E. Donlon,Fiona O’Connell,Caoimhe Gaughan,Cillian O’Donovan,Jason McGrath,Andrew D. Sheppard,Conall Hayes,Ross King,Hugo C. Temperley,Michael MacLean,Christine Bulter,Anshul Bhardwaj,Jenny Moore,Claire Donohoe,Narayanasamy Ravi,Melissa J. Conroy,John V. Reynolds,Joanne Lysaght	2022	14
5	FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy Journal of Cancer Research and Clinical Oncology ·Maria Davern,Noel E. Donlon,Andrew Sheppard,Klaudia Majcher,Fiona O’ Connell,Aisling B. Heeran,Malika Grant,Robert A. Farrell,Conall Hayes,Dara Bracken‐Clarke,Melissa J. Conroy,Emma Foley,Dermot O’Toole,Anshul Bhardwaj,Narayanasamy Ravi,John V. Reynolds,Stephen G. Maher,Jacintha O’ Sullivan,Joanne Lysaght	2022	1
6	Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells Translational Oncology ·Maria Davern,Noel E. Donlon,Andrew Sheppard,Fiona O’ Connell,Conall Hayes,Anshul Bhardwaj,Emma Foley,Dermot O’Toole,Niamh Lynam‐Lennon,Narayanasamy Ravi,John V. Reynolds,Stephen G. Maher,Joanne Lysaght	2021	12
7	The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling Cancers ·Noel E. Donlon,Maria Davern,Andrew Sheppard,Robert Power,Fiona O’Connell,Aisling B. Heeran,Ross King,Conall Hayes,Anshul Bhardwaj,J.J. Phelan,Margaret R. Dunne,Narayanasamy Ravi,Claire L. Donohoe,Jacintha O’Sullivan,John V. Reynolds,Joanne Lysaght	2021	4
8	Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity Cancer Letters ·NE Donlon,Robert Power,Conall Hayes,John V. Reynolds,Joanne Lysaght	2021	134
9	Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines Cancers ·Noel E. Donlon,Andrew Sheppard,Maria Davern,Fiona O’Connell,J.J. Phelan,Robert Power,Timothy Nugent,Kate Dinneen,John Aird,John Greene,Paul Nevins Selvadurai,Anshul Bhardwaj,Emma K. Foley,Narayanasamy Ravi,Claire L. Donohoe,John V. Reynolds,Joanne Lysaght,Jacintha O’Sullivan,Margaret R. Dunne	2020	15
10	Selective effects of radiotherapy on viability and function of invariant natural killer T cells in vitro Radiotherapy and Oncology ·Ashanty M. Melo,Stephen G. Maher,Seónadh M. O’Leary,Derek G. Doherty,Joanne Lysaght	2020	3
11	CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies Cancer Immunology Immunotherapy ·Ashanty M. Melo,Melissa J. Conroy,Emma K. Foley,Éilis Dockry,Eamon P. Breen,John V. Reynolds,Joanne Lysaght,Derek G. Doherty	2020	9
12	The ‘obesity paradox’ in action with cancer immunotherapy Nature Reviews Endocrinology ·Joanne Lysaght	2019	15
13	Human dorsal root ganglion pulsed radiofrequency treatment modulates cerebrospinal fluid lymphocytes and neuroinflammatory markers in chronic radicular pain Brain Behavior and Immunity ·Basabjit Das,Melissa J. Conroy,David Moore,Joanne Lysaght,Connail McCrory	2018	30
14	Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells Glycobiology ·Ashanty M. Melo,Lei Zhang,Éilis Dockry,Andreea Petrasca,Yasmeen G. Ghnewa,Eamon P. Breen,Maria E. Morrissey,Ciara E. O’Reilly,Robyn Bruen,Andrew O’Meara,Joanne Lysaght,Xiangming Zhu,Derek G. Doherty	2018	13
15	Parallel Profiles of Inflammatory and Effector Memory T Cells in Visceral Fat and Liver of Obesity-Associated Cancer Patients Inflammation ·Melissa J. Conroy,Karen Galvin,Suzanne L. Doyle,María Kavanagh,Ann-Marie Mongan,Aoife Cannon,Gillian Moore,John V. Reynolds,Joanne Lysaght	2016	18
16	Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment Frontiers in Oncology ·Mary B. Mockler,Melissa J. Conroy,Joanne Lysaght	2014	68
17	The SGBS cell strain as a model for the in vitro study of obesity and cancer Clinical & Translational Oncology ·Emma H. Allott,Elizabeth Oliver,Joanne Lysaght,Steven G. Gray,John V. Reynolds,Helen M. Roche,Graham P. Pidgeon	2012	30
18	The microtubule targeting agent PBOX-15 inhibits integrin-mediated cell adhesion and induces apoptosis in acute lymphoblastic leukaemia cells International Journal of Oncology ·Joanne Lysaght,Navin Kumar Verma,Elaina N. Maginn,Jacqueline Ryan,Giuseppe Campiani,Daniela M. Zisterer,D. Clive Williams,Paul Browne,Mark Lawler,Anthony M. McElligott	2012	9
19	IGF-1 and Its Receptor in Esophageal Cancer: Association with Adenocarcinoma and Visceral Obesity The American Journal of Gastroenterology ·Suzanne L. Doyle,Claire L. Donohoe,Stephen P. Finn,Julia Howard,Fiona E. Lithander,John V. Reynolds,Graham P. Pidgeon,Joanne Lysaght	2011	85
20	Alterations in DNA Repair Efficiency are Involved in the Radioresistance of Esophageal Adenocarcinoma Radiation Research ·Niamh Lynam‐Lennon,John V. Reynolds,Graham P. Pidgeon,Joanne Lysaght,Laure Marignol,Stephen G. Maher	2010	65

About Joanne Lysaght

Joanne Lysaght is a scholar working on Immunology, Oncology and Surgery, having authored 95 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (32 papers), Esophageal Cancer Research and Treatment (29 papers), Immune Cell Function and Interaction (24 papers), Immunotherapy and Immune Responses (11 papers), Immune cells in cancer (11 papers), Adipokines, Inflammation, and Metabolic Diseases (10 papers), Gastric Cancer Management and Outcomes (9 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (858 citations) and Cancer Research (497 citations). Joanne Lysaght has collaborated with scholars based in Ireland, Canada and United Kingdom. Frequent co-authors include John V. Reynolds, Claire L. Donohoe, Graham P. Pidgeon, Suzanne L. Doyle, Melissa J. Conroy, Stephen Todryk, Kingston H. G. Mills, Andrew Jarnicki, Jacintha O’Sullivan and Adriele Prina‐Mello. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact